First Time Loading...

Basilea Pharmaceutica AG
SIX:BSLN

Watchlist Manager
Basilea Pharmaceutica AG Logo
Basilea Pharmaceutica AG
SIX:BSLN
Watchlist
Price: 41.9 CHF 2.95%
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one BSLN stock under the Base Case scenario is 94.91 CHF. Compared to the current market price of 41.9 CHF, Basilea Pharmaceutica AG is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSLN Relative Value
Base Case
94.91 CHF
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
73
vs Industry
75
Median 3Y
3.3
Median 5Y
3.6
Industry
8.3
Forward
2.5
More Details
48.1
P/E
P/E
Price to Earnings
48.1
vs History
23
vs Industry
4
Median 3Y
9.4
Median 5Y
-11.3
Industry
26.8
Forward
13.5
More Details
35.3
P/OCF
P/OCF
Price to OCF
35.3
vs History
9
vs Industry
5
Median 3Y
-9.1
Median 5Y
-8.7
Industry
23.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-12
Median 5Y
-10.3
Industry
21.4
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
2
Median 3Y
-7.3
Median 5Y
-6.7
Industry
2.6
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
63
vs Industry
63
Median 3Y
3.2
Median 5Y
3.9
Industry
7.5
Forward
2.7
More Details
4.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.1
vs History
63
vs Industry
61
Median 3Y
3.9
Median 5Y
4.6
Industry
9.2
More Details
25.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.5
vs History
28
vs Industry
5
Median 3Y
24.5
Median 5Y
-16
Industry
4.5
Forward
10.9
More Details
27.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.6
vs History
28
vs Industry
5
Median 3Y
26.5
Median 5Y
-15.6
Industry
4.4
Forward
12.2
More Details
37.2
EV/OCF
EV/OCF
Enterprise Value to OCF
37.2
vs History
9
vs Industry
5
Median 3Y
-10.4
Median 5Y
-9.3
Industry
5.6
More Details
40.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
40.1
vs History
9
vs Industry
4
Median 3Y
-10.1
Median 5Y
-9.2
Industry
3.4
More Details
4.9
EV/IC
EV/IC
Enterprise Value to IC
4.9
vs History
61
vs Industry
34
Median 3Y
4.7
Median 5Y
6.2
Industry
5
More Details

Multiples Across Competitors

BSLN Competitors Multiples
Basilea Pharmaceutica AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Basilea Pharmaceutica AG
SIX:BSLN
494.5m CHF 3.2 48.1 25.5 27.6
US
Abbvie Inc
NYSE:ABBV
287.1B USD 5.3 59.6 12.9 19.7
US
Amgen Inc
NASDAQ:AMGN
161.1B USD 5.5 42.8 18.2 30
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
106.9B USD 8.2 27.7 22.4 24.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.7B USD 10.7 29.2 23.4 24.5
AU
CSL Ltd
ASX:CSL
135.1B AUD 6.3 36 21.8 27
US
Gilead Sciences Inc
NASDAQ:GILD
81.6B USD 3 168.5 6.8 8.9
US
Moderna Inc
NASDAQ:MRNA
46.4B USD 9 -7.8 -8.4 -7.5
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.9B USD 3.3 27.3 14 17.5
KR
Celltrion Inc
KRX:068270
40.1T KRW 18.5 74.9 45.8 63.1

See Also

Summary
BSLN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSLN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSLN stock valuation using valuation multiples.
Wall Street Estimates
BSLN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSLN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.